Eliminating the label exclusion enables clinicians to consider axi-cel for relapsed/refractory primary CNS lymphoma, despite the disease not being explicitly added as an indicated population. Phase 1 ...

In an interview with CURE, Dr. Lakshmi Nayak explains how an FDA label update expands Yescarta access for relapsed or refractory primary CNS lymphoma. In an interview with CURE, Dr. Lakshmi Nayak, a ...

A treatment regimen of penpulimab combined with rituximab, high-dose methotrexate, and cytarabine (Pen-RMA) achieved its primary endpoint in newly diagnosed primary central nervous system lymphoma ...

Readers will learn how veterinary oncologists stage and treat canine lymphoma using modern multi-agent chemotherapy and palliative care.

A Bolton dad has raised concern after his son was not told of the potential severity of lymphoma, an inquest heard.

Debi Weiss thought her fatigue and weakness was a seasonal illness, but her condition quickly worsened.

A rockstar who previously survived severe mental health battles is refusing cancer treatment, leaving them with '2-3 years' to say goodbye to loved ones ...

Management prioritizes 5%–10% weight loss and acetazolamide titration guided by Frisén grading, OCT, and visual fields; refractory or vision-threatening disease may need ONSF or CSF shunting.

When a high-performance fitness instructor’s "exhaustion" turned out to be a deadly lymphoma, a cutting-edge "Pac-Man" ...

HealthDay News — Features that characterize presentation of vitreoretinal lymphoma are described in an article published online March 1 in Clinical & Experimental Ophthalmology.

Debi Weiss went to the doctor's office with what she thought were worsening flu symptoms, but got a very different diagnosis ...

Peripheral T-cell lymphoma, not otherwise specified (PTCL-NOS), is a rare subtype of non-Hodgkin lymphoma that frequently presents with multiorgan involvement. We report a diagnostically challenging ...